2017 Health for Humanity Report
Our Approach
Our Approach
Our Approach
GRI
Global Reporting Initiative
102-44
Key topics and concerns raised
102-46
Defining report content and topic Boundaries
102-47
List of material topics
103-1
Explanation of the material topic and its Boundary
Our Approach

Setting Priorities

GRI
Global Reporting Initiative
102-44
Key topics and concerns raised
102-46
Defining report content and topic Boundaries
102-47
List of material topics
103-1
Explanation of the material topic and its Boundary

Stakeholder expectations and the business environment in which we operate constantly evolve. Our Priority Topics Assessment (PTA) process helps us identify and prioritize the environmental, social and governance (ESG) issues that matter most to our stakeholders and our Company. We use the results of this process to ensure that our citizenship and sustainability activities and reporting are aligned with the needs of various stakeholder groups and our own business interests. We have been conducting PTAs since 2008, with our most recent assessment conducted in 2016. The stakeholder feedback from that 2016 assessment continues to inform our reporting in 2017. For a detailed description of the 2016 PTA process, methodology, and definitions of topics click here.

Priority Topics

While the priority topics that we focus on remain the same, we have re-organized the structure of our Health for Humanity Report by grouping our reporting on various topics into five main sections.

We believe this structure demonstrates a more holistic picture of our Company’s performance on ESG issues, and reflects the core focus areas of our citizenship and sustainability approach. In many cases, priority topics are reflected in multiple sections because of their cross-cutting nature. Our new products and solutions not only advance Better Health for All, but are also examples of our Innovation culture.

Global Ranking of Priority Topics

More Resources
You are leaving jnj.com and entering a third party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties. Continue